share_log

Why The 29% Return On Capital At APT Medical (SHSE:688617) Should Have Your Attention

Why The 29% Return On Capital At APT Medical (SHSE:688617) Should Have Your Attention

爲什麼APt Medical(SHSE:688617)的資本回報率達到29%應該引起您的注意
Simply Wall St ·  08/30 20:23

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Amongst other things, we'll want to see two things; firstly, a growing return on capital employed (ROCE) and secondly, an expansion in the company's amount of capital employed. Ultimately, this demonstrates that it's a business that is reinvesting profits at increasing rates of return. With that in mind, the ROCE of APT Medical (SHSE:688617) looks great, so lets see what the trend can tell us.

你知道有一些財務指標可以提供潛在倍增的線索嗎?其中,我們將希望看到兩個方面;首先,資本僱用回報率(ROCE)的增長,其次,公司資本僱用的擴大。最終,這表明這是一個以遞增的回報率重新投資利潤的業務。考慮到這一點,APt Medical(上證交易所:688617)的ROCE看起來很不錯,所以讓我們看一下趨勢能告訴我們什麼。

Understanding Return On Capital Employed (ROCE)

上面您可以看到蒙托克可再生能源現行ROCE與之前資本回報的比較,但過去只能知道這麼多。如果您感興趣,可以查看我們免費的蒙托克可再生能源分析師報告,了解分析師的預測。

For those who don't know, ROCE is a measure of a company's yearly pre-tax profit (its return), relative to the capital employed in the business. To calculate this metric for APT Medical, this is the formula:

對於那些不了解的人來說,ROCE是一個公司的年度稅前利潤(回報)相對於業務中所使用的資本的度量。要計算APt Medical的這個指標,使用以下公式:

Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities)

資產僱用回報率(ROCE)是指企業利潤,即企業稅前利潤除以企業投入的總資本(負債加股權)。如果ROCE高於企業財務成本的承受能力,那麼企業就會創造出更多的價值。

0.29 = CN¥634m ÷ (CN¥2.7b - CN¥541m) (Based on the trailing twelve months to June 2024).

0.29 = CN¥63400萬 ÷ (CN¥27億 - CN¥541m) (基於截至2024年6月的過去十二個月)

Thus, APT Medical has an ROCE of 29%. That's a fantastic return and not only that, it outpaces the average of 6.0% earned by companies in a similar industry.

因此,APt Medical的ROCE爲29%。這是一個很棒的回報,而且不僅如此,它超過了同行業公司平均6.0%的回報。

1725063837878
SHSE:688617 Return on Capital Employed August 31st 2024
SHSE:688617在2024年8月31日的資本僱用回報率

In the above chart we have measured APT Medical's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for APT Medical .

在上圖中,我們對APt Medical之前的ROCE進行了測量,但未來可能更重要。如果您想了解分析師對未來的預測,請查看我們爲APt Medical準備的免費分析報告。

What The Trend Of ROCE Can Tell Us

儘管如此,當我們看 enphase energy (納斯達克股票代碼:ENPH) 的時候,它似乎並沒有完全符合這些要求。

APT Medical is displaying some positive trends. Over the last five years, returns on capital employed have risen substantially to 29%. The company is effectively making more money per dollar of capital used, and it's worth noting that the amount of capital has increased too, by 499%. The increasing returns on a growing amount of capital is common amongst multi-baggers and that's why we're impressed.

APt Medical顯示出一些積極的趨勢。在過去五年中,資本利用率回報率大幅提高至29%。公司在每一美元的資本使用上實際賺得更多的錢,值得注意的是資本的金額也增加了499%。在日益增長的資本數量上獲得日益增長的回報率,在多倍股中是常見的,這也是我們印象深刻的原因。

The Key Takeaway

重要提示

In summary, it's great to see that APT Medical can compound returns by consistently reinvesting capital at increasing rates of return, because these are some of the key ingredients of those highly sought after multi-baggers. Since the stock has returned a solid 54% to shareholders over the last three years, it's fair to say investors are beginning to recognize these changes. Therefore, we think it would be worth your time to check if these trends are going to continue.

總而言之,令人高興的是,APt Medical能夠通過持續以日益增加的回報率再投資資本來實現複利回報,因爲這些是追求高收益的多倍股的關鍵因素之一。由於該股在過去三年中爲股東帶來了可觀的54%回報,因此可以說投資者開始認識到這些變化。因此,我們認爲值得您花時間檢查這些趨勢是否會繼續。

If you want to continue researching APT Medical, you might be interested to know about the 1 warning sign that our analysis has discovered.

如果您想繼續研究APt Medical,您可能會對我們的分析發現的1個風險警告感興趣。

If you'd like to see other companies earning high returns, check out our free list of companies earning high returns with solid balance sheets here.

如果您想看到其他公司獲得高回報,請在此查看我們免費的高回報、堅實財務狀況的公司列表。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論